Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bank of America Corp (BAC) Don’t Overlook This Multi-Billion-Dollar B of A Risk

Page 1 of 3

This is the third in a series of five articles covering Bank of America Corp (NYSE:BAC)‘s legal problems since the financial crisis. Click here to read the first installment, and here to read the second installment.

Don’t believe what the media says about Bank of America Corp (NYSE:BAC) or its CEO Brian Moynihan. Is he a bit monotone in media appearances? Perhaps. A smidge boring? Sure. But inept? Certainly not.

Bank of America Corp (NYSE:BAC)Since taking the helm in 2010, Moynihan has adroitly navigated the bank through arguably the most treacherous legal battles ever waged against a company that wasn’t in the throes of bankruptcy. He’s overseen multi-billion-dollar settlements with the U.S. Justice Department, state attorney generals, banking regulators, the Securities and Exchange Commission, former shareholders of Merrill Lynch, Fannie Mae and Freddie Mac, and the Federal Trade Commission. Before Moynihan can declare victory in its ongoing legal war, however, he must first navigate the bank past a series of lawsuits by private investors in Countrywide Financial’s mortgage-backed securities and a particularly litigious bunch of monoline insurance companies.

Putting the monoline claims into perspective
If the number of lawsuits filed against B of A resembles an unsolvable puzzle, here’s a simple framework to keep in mind. The bank faces liability under three legal theories:

1). Breach of contract

2). Securities fraud

3). Malfeasance in mortgage servicing

The breach of contract claims can be further broken down into:

1). Those involving mortgages sold by Countrywide to government-sponsored agencies Fannie Mae and Freddie Mac.

2). Those involving private institutions which invested in Countrywide’s mortgage-backed securities (MBS).

3). And, those involving monoline insurance companies that insured particular tranches of the private-label MBSes.

What we’re concerned about here are the claims in the third category — the vast majority of which are tied up in a New York state court.


As a group, the monoline claims are the least alarming when it comes to monetary damages. To put them in perspective, between 2004 and 2008, Countrywide sold $846 billion worth of mortgages to Fannie Mae and Freddie Mac, $111 billion of which have since either defaulted or are severely delinquent — that is, they’re more than 180 days past due. Over the same time period, the mortgage originator packaged $716 billion worth of mortgages into hundreds of MBSes that were sold to private investors. A cool $190 billion of that group have defaulted or are severely delinquent. By comparison, according to B of A’s third-quarter 10-Q filing, Countrywide sold only $184.5 billion of the loans originated between 2004 and 2008 into monoline-insured securitizations, $52.6 billion of which are now in default or severely delinquent.

As they say, a picture is worth a thousand words, and when we stack up the three groups, it’s easy to see the disparity.


Source: Bank of America’s 3Q12 10-Q, pages 65-66.

This isn’t to say that monoline claims don’t cause sleepless nights for B of A executives — the damages will unquestionably amount to billions of dollars. Even more worrisome is the possibility that any of a number of critical legal issues in these cases will be decided against B of A. Those decisions could then go on to influence the outcome of parallel lawsuits, and even incentivize new counterparties to sue.

Page 1 of 3

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!